{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:32:47Z","timestamp":1786653167643,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Androl"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/1008-682x.135983","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T03:37:09Z","timestamp":1416195429000},"page":"143","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction"],"prefix":"10.4103","volume":"17","author":[{"given":"KangSeo","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SoonHyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SungWoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BongYun","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IeByung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KyungWan","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YeonAh","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TaeHwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JaeMin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1008-682X.135983-1","first-page":"83","volume-title":"Impotence.NIH Consensus Development Panel on Impotence","author":"NIH","year":"1993","journal-title":"JAMA"},{"key":"key-10.4103\/1008-682X.135983-2","first-page":"788","volume-title":"Sexual function in men with diabetes type 2: association with glycemic control","author":"Romeo","year":"2000","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.135983-3","first-page":"279","volume-title":"The prevalence of diabetic impotence","author":"McCulloch","year":"1980","journal-title":"Diabetologia"},{"key":"key-10.4103\/1008-682X.135983-4","first-page":"108","volume-title":"Corporal reactivity to adenosine and prostaglandin E1 in alloxan-induced diabetic rabbit corpus cavernosum, and the effect of insulin therapy","author":"Ayan","year":"1999","journal-title":"BJU Int"},{"key":"key-10.4103\/1008-682X.135983-5","first-page":"1587","volume-title":"Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle","author":"Azadzoi","year":"1992","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.135983-6","first-page":"1296","volume-title":"Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus","author":"Boulton","year":"2001","journal-title":"Diabetologia"},{"key":"key-10.4103\/1008-682X.135983-7","first-page":"421","volume-title":"Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial.Sildenafil Diabetes Study Group","author":"Rendell","year":"1999","journal-title":"JAMA"},{"key":"key-10.4103\/1008-682X.135983-8","first-page":"279","volume-title":"Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial","author":"Stuckey","year":"2003","journal-title":"Diabetes Care"},{"key":"key-10.4103\/1008-682X.135983-9","first-page":"804","volume-title":"Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation","author":"Hatzimouratidis","year":"2010","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.135983-10","first-page":"138","volume-title":"Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction","author":"Hatzichristou","year":"2008","journal-title":"Diabet Med"},{"key":"key-10.4103\/1008-682X.135983-11","first-page":"415","volume-title":"Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction","author":"McMahon","year":"2005","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.135983-12","first-page":"37","volume-title":"Chronic administration of Sildenafil improves markers of endothelial function in men with type 2 diabetes","author":"Aversa","year":"2008","journal-title":"Diabet Med"},{"key":"key-10.4103\/1008-682X.135983-13","first-page":"1336","volume-title":"Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes","author":"Desouza","year":"2002","journal-title":"Diabetes Care"},{"key":"key-10.4103\/1008-682X.135983-14","first-page":"214","volume-title":"Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk","author":"Rosano","year":"2005","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.135983-15","first-page":"661","volume-title":"Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction","author":"Salem","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"key-10.4103\/1008-682X.135983-16","first-page":"946","volume-title":"The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction","author":"Paick","year":"2008","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.135983-17","first-page":"2209","volume-title":"Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial","author":"Park","year":"2010","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.135983-18","first-page":"2048","volume-title":"A therapeutic confirmatory study to assess the safety and efficacy of Zydena (udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus","author":"Moon","year":"2011","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.135983-19","first-page":"822","volume-title":"The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"key-10.4103\/1008-682X.135983-20","first-page":"76","volume-title":"Tadalafil is efficacious in Black American and Hispanic men with erectile dysfunction: results from multiple observations in men with erectile dysfunction in national tadalafil study in the US (MOMENTUS)","author":"Gomery","year":"2007","journal-title":"Int J Impot Res"},{"key":"key-10.4103\/1008-682X.135983-21","first-page":"169","volume-title":"Non-inferiority trials: design concepts and issues - The encounters of academic consultants in statistics","author":"D\u2032Agostino","year":"2003","journal-title":"Stat Med"},{"key":"key-10.4103\/1008-682X.135983-22","first-page":"36","volume-title":"Trials to assess equivalence: the importance of rigorous methods","author":"Jones","year":"1996","journal-title":"BMJ"},{"key":"key-10.4103\/1008-682X.135983-23","first-page":"292","volume-title":"Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil","author":"McMahon","year":"2004","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.135983-24","first-page":"858","volume-title":"Response to on-demand vardenafil was improved by its daily usage in hypertensive men","author":"Javaroni","year":"2012","journal-title":"Urology"},{"key":"key-10.4103\/1008-682X.135983-25","first-page":"820","volume-title":"A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy","author":"Kim","year":"2014","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.135983-26","first-page":"204","volume-title":"Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE study","author":"Zumb\u00e9","year":"2008","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.135983-27","first-page":"134","volume-title":"Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trial","author":"Sommer","year":"2007","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.135983-28","first-page":"3700","volume-title":"The triad: erectile dysfunction - endothelial dysfunction - cardiovascular disease","author":"Vlachopoulos","year":"2008","journal-title":"Curr Pharm Des"},{"key":"key-10.4103\/1008-682X.135983-29","first-page":"928","volume-title":"Male erectile dysfunction and cardiovascular disease: is there an intimate nexus?","author":"Chew","year":"2008","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.135983-30","first-page":"225","volume-title":"Endothelial dysfunction links erectile dysfunction to heart disease","author":"Kirby","year":"2005","journal-title":"Int J Clin Pract"},{"key":"key-10.4103\/1008-682X.135983-31","first-page":"200","volume-title":"Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study","author":"Aversa","year":"2007","journal-title":"Int J Impot Res"},{"key":"key-10.4103\/1008-682X.135983-32","first-page":"245","volume-title":"Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction","author":"Burnett","year":"2009","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.135983-33","first-page":"176","volume-title":"Daily use of sildenafil improves endothelial function in men with type 2 diabetes","author":"Deyoung","year":"2012","journal-title":"J Androl"},{"key":"key-10.4103\/1008-682X.135983-34","first-page":"170","volume-title":"Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease","author":"Robinson","year":"2006","journal-title":"Heart"},{"key":"key-10.4103\/1008-682X.135983-35","first-page":"777","volume-title":"Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study","author":"Goldstein","year":"2003","journal-title":"Diabetes Care"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:32:46Z","timestamp":1786649566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1008-682X.135983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"alternative-id":["135983"],"URL":"https:\/\/doi.org\/10.4103\/1008-682x.135983","relation":{},"ISSN":["1008-682X"],"issn-type":[{"value":"1008-682X","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}